Grazoprevir is a macrocyclic compound used as an active pharmaceutical ingredient in the manufacturing of antiviral medications. It functions as an inhibitor of the hepatitis C virus NS3/4A protease and is a component of combination regimens for research and pharmaceutical production.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Grazoprevir?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Grazoprevir
pharmaceutical raw material
Repaglinide
pharmaceutical raw material
Lefamulin acetate
pharmaceutical raw material
Vericiguat
pharmaceutical raw material
Ceralasertib
pharmaceutical raw material
Voxilaprevir
pharmaceutical raw material
(1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide
OBMNJSNZOWALQB-NCQNOWPTSA-N
CC(C)(C)[C@H]1C(=O)N2C[C@@H](C[C@H]2C(=O)N[C@@]3(C[C@H]3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCC[C@@H]7C[C@H]7OC(=O)N1
Sourcing Grazoprevir?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.